Clinical Trials
3 trialsNCT05455619 2026-04-22
Amelia-1
SynDevRx, Inc.
Phase 1/2 Recruiting
NCT04899349 2024-10-09
EPIK-B4
Novartis
Phase 2 Terminated
NCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed